4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Lower Back Pain: new trials by email Literature Review of Lower Back Pain trials Research Report on Lower Back Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back Carisoprodol SR 700 mg, Carisoprodol SR 500 mg, Placebo - Lower Back Pain | Phase 3 | Completed | Meda Pharmaceuticals | 830 | 2008-04-01 | 2012-11-21 |
| A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back Carisoprodol SR, Placebo - Lower Back Pain | Phase 3 | Completed | Meda Pharmaceuticals | 840 | 2008-04-01 | 2011-11-09 |
| A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain Oxycodone CR, Tapentadol (CG5503) ER - Osteoarthritis, Hip, Osteoarthritis, Knee | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1123 | 2006-11-01 | 2014-04-29 |
| Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy Oxymorphone ER - Cancers, Pain, Lower Back Pain | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 239 | 2001-03-01 | 2009-05-19 |
Low Back Pain (4) · Pain (2) · Back Pain (1) · Neoplasms (1) · Osteoarthritis (1) · Osteoarthritis, Hip (1) · Osteoarthritis, Knee (1)
Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Back Pain (3) · Pain (2) · Arthritis (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Rheumatic Diseases (1)
Carisoprodol (2) · Tablets (1) · Tapentadol (1)
Meda Pharmaceuticals (2) · Endo USA Inc., a Keenova Therapeutics Company (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)
United States (4) · Canada (1)